EUVIMEDEUVIMED entdecken
Übersichtsarbeit

An Evaluation of the Impact of PD‐1 Pathway Blockade on Reproductive Safety of Therapeutic PD‐1 Inhibitors

Frederique M Poulet, Jayanthi J Wolf, Danuta J Herzyk, Joseph J DeGeorge

Birth Defects Research Part B: Developmental and Reproductive Toxicology · 2016-04 · 107 (2) · 108-119

DOI: 10.1002/bdrb.21176 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Birth Defects Research Part B: Developmental and Reproductive Toxicology, online erschienen am 07.04.2016. Verfasst von Frederique M Poulet und 3 weiteren Autor:innen. Beteiligte Einrichtung: Merck Research Laboratories, Kenilworth, New Jersey. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 83 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This report discusses the principles of reproductive toxicity risk assessment for biopharmaceuticals blocking the PD‐1/programmed cell death ligand 1 (PD‐L1) pathway, which have been developed for the treatment of patients with advanced malignancies. The PD‐1/PD‐L1 pathway is a T‐cell co‐inhibitory pathway that normally maintains immune tolerance to self. Its role in pregnancy is to maintain immune tolerance to the fetal allograft. In cancer patients, this signaling pathway is hijacked by some neoplasms to avoid immune destruction. PD‐1/PD‐L1‐blocking agents enhance functional activity of the target lymphocytes to eventually cause immune rejection of the tumor. A therapeutic blockade of PD‐1/PD‐L1 pathway that occurs at full target engagement provides a unique challenge to address the risk to pregnancy because disruption of the same pathway may also reduce or abrogate maternal immune tolerance to the fetal alloantigens inherited through the father. Typically, nonclinical reproductive and developmental toxicity (DART) studies in animals (rats and rabbits) with clinical drug candidates are conducted to identify potential risk in humans and to determine exposure margin for the effects on reproduction as part of the risk assessment. However, for biopharmaceuticals for which the desired mechanism of action cannot be separated from potential deleterious effects to the fetus and when the only relevant toxicology species is nonhuman primate (NHP), the risk to reproduction can be predicted by a mechanism‐based assessment using data generated from murine surrogate models as supportive information without conducting DART in NHPs. Such an approach has been used in the evaluation of pregnancy risk of anti‐PD‐1 agent, pembrolizumab, and has been demonstrated as an important alternative to performing DART studies in NHPs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntibodies, Monoclonal, HumanizedAntineoplastic AgentsB7-H1 AntigenDisease Models, AnimalDrug Evaluation, PreclinicalDrug-Related Side Effects and Adverse ReactionsFemaleHumansImmunotherapyMiceNeoplasmsPlacentaPregnancyReproductionRisk AssessmentSignal TransductionXenograft Model Antitumor Assays

Stichwörter der Autor:innen

PD-1/PD-L1alternative modelsbiopharmaceuticalsfetuspregnancyreproductive toxicityrisk assessment

Substanzen

Antibodies, Monoclonal, HumanizedAntineoplastic AgentsB7-H1 Antigenpembrolizumab

Autor:innen und Institutionen

  • Merck Research Laboratories, Kenilworth, New Jersey.
  • Merck Research Laboratories, West Point, Pennsylvania.

Zitieren

APA

Poulet, F. M., Wolf, J. J., Herzyk, D. J., & DeGeorge, J. J. (2016). An Evaluation of the Impact of PD‐1 Pathway Blockade on Reproductive Safety of Therapeutic PD‐1 Inhibitors. Birth Defects Research Part B: Developmental and Reproductive Toxicology, 107(2), 108-119. https://doi.org/10.1002/bdrb.21176

Vancouver

Poulet FM, Wolf JJ, Herzyk DJ, DeGeorge JJ. An Evaluation of the Impact of PD‐1 Pathway Blockade on Reproductive Safety of Therapeutic PD‐1 Inhibitors. Birth Defects Research Part B: Developmental and Reproductive Toxicology. 2016;107(2):108-119. doi:10.1002/bdrb.21176

BibTeX
@article{Poulet2016,
  author = {Poulet, Frederique M and Wolf, Jayanthi J and Herzyk, Danuta J and DeGeorge, Joseph J},
  title = {An Evaluation of the Impact of PD‐1 Pathway Blockade on Reproductive Safety of Therapeutic PD‐1 Inhibitors},
  journal = {Birth Defects Research Part B: Developmental and Reproductive Toxicology},
  year = {2016},
  volume = {107},
  number = {2},
  pages = {108--119},
  doi = {10.1002/bdrb.21176}
}
Kostenlos starten →